TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors

Molecular Endocrinology

Volumn 12, Issue 1, 1998, Pages 4-18

  Powers, C Andrew ^a,c   Mathur, Mukul ^a   Raaka, Bruce M ^a   Ron, David ^a,b   Samuels, Herbert H ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUTATHIONE TRANSFERASE; RETINOID X RECEPTOR; STEROID; THYROID HORMONE;

ANIMAL CELL; ARTICLE; DELETION MUTANT; DNA BINDING; DNA SEQUENCE; DRUG RECEPTOR BINDING; LIPOSARCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RNA PROCESSING; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0031915988     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.1.0043     Document Type: Article

References (84)

1. Evans RM 1988 The steroid and thyroid hormone receptor super-family. Science 13:889-895
2. Carson-Jurica M, Schrader WT, O'Malley BW 1990 Steroid receptor family: structure and functions. Endocr Rev 11:201-219
3. Forman BM, Samuels HH 1990 Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol Endocrinol 4:1293-1301
4. Truss M, Beato M 1993 Steroid hormone receptors: interactions with deoxyribonucleic acid and transcription factors. Endocr Rev 4:459-479
5. Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HH 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol 13:5725-5737
6. Qi J-S, Desai-Yajnik V, Greene ME, Raaka BM, Samuels HH 1995 The ligand binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation. Mol Cell Biol 15:1817-1825
7. Baniahmad A, Kohne AC, Renkawitz R 1992 A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product, and in the retinoic acid receptor. EMBO J 11:1015-1023
8. Nagpal S, Friant S, Nakshatri H, Chambon P 1993 RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J 12:2349-2360
9. Godowski PJ, Rusconi S, Miesfeld R, Yamamoto KR 1987 Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature 325:365-368
10. Hollenberg SM, Giguere V, Segui P, Evans RM 1987 Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39-46
11. Kumar V, Green S, Stack G, Berry M, Jin J, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
12. Waterman ML, Adler S, Nelson C, Greene GL, Evans RM, Rosenfeld MG 1988 A single domain of the estrogen receptor confers deoxynucleic acid binding and transcriptional regulation. Mol Endocrinol 2:14-21
13. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
14. Simental JA, Sar M, Lane MV, French FS, Wilson EM 1991 Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518
15. Jenster G, van der Korput HAGM, Trapman J, Brinkmann AO 1995 Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341-7346
16. Pham TA, Elliston JF, Nawaz Z, McDonnell DP, Tsai M, O'Malley BW 1991 Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc Natl Acad Sci USA 88:3125-3129
17. Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakdel F, Reese JC, Schodin D, Wrenn CK 1993 Hormone binding and transcription activation by estrogen receptors: analysis using mammalian and yeast systems. J Steroid Biochem Mol Biol 47:39-48
18. Metzger D, Berry M, Ali S, Chambon P 1995 Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9:579-591
19. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
20. Brent GA, Larsen PR, Hamey JW, Koenig RJ, Moore DD 1989 Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected beta type thyroid hormone receptor. J Biol Chem 264:178-182
21. Baniahmad A, Steiner C, Kohne AC, Renkawitz R 1990 Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell 61:505-514
22. Umesono K, Murakami KK, Thompson CC, Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D receptors. Cell 65:1255-1266
23. Schena M, Freedman LP, Yamamoto KR 1989 Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev 3:1590-1601
24. Lefstin JA, Thomas JR, Yamamoto KR 1994 Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev 8:2842-2856
25. Zandi E, Galli I, Dobbeling U, Rusconi S 1993 Zinc finger mutations that alter domain interactions in the glucocorticoid receptor. J Mol Biol 230:124-136
26. Meyer M, Gronemeyer H, Turcotte B, Bocquel M, Tasset D, Chambon P 1989 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442
27. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 64:1455-1458
28. Folkers GE, van der Saag PT 1995 Adenovirus E1A functions as a cofactor for retinoic acid receptor β (RARβ) through direct interaction with RARβ. Mol Cell Biol 15:5868-5878
29. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD 1995 Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94
30. LeDouarin B, Zechel C, Garnier J-M, Iutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
31. Onate SA, Tsai SY, Tsai M-J-, O'Malley BW 1995 Sequence and characterization of a coactivator of the steroid hormone receptor superfamily. Science 270:1354-1357
32. Crozat A, Aman P, Mandahl N, Ron D 1993 Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640-644
33. Rabbitts TH, Forster A, Larson R, Nathan P 1993 Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4:175-180
34. Ubeda M, Wang X-Z, Zinszner H, Wu I, Habener JF, Ron D 1996 Stress-induced binding of the transcription factor CHOP to a novel DNA control element. Mol Cell Biol 16:1478-1489
35. Zinszner H, Albalat R, Ron D 1994 A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 8:2513-2526
36. Yuryev A, Patturajan M, Litingtung Y, Joshi RV, Gentile C, Gebara M, Corden JL 1996 The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc Natl Acad Sci USA 93:6975-6980
37. Du L, Warren SL 1997 A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing. J Cell Biol 136:5-18
38. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, Patterson SD, Wickens M, Bentley DL 1997 The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357-361
39. Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L 1996 hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the proto-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15:5022-5031
40. Forman BM, Yang C-R, Au M, Casanova J, Ghysdael J, Samuels HH 1989 A domain containing leucine zipper like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol 3:1610-1626
41. Hadzic E, Desai-Yajnik V, Helmer E, Guo S, Koudinova N, Casanova J, Raaka BM, Samuels HH 1995 A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor α is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol 15:4507-4517
42. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK, Rosenfeld MG 1991 RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
43. Marks MS, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikodem VM, Ozato K 1992 H-2RIIBP (RXR-β) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J 11:1419-1435
44. Zhang X-K, Salberg G, Lee M-O, Pfahl M 1994 Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol Cell Biol 14:4311-4323
45. Mader S, Chen J-Y, Chen Z, White J, Chambon P, Gronemeyer H 1993 The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J 12:5029-5041
46. Zechel C, Shen X-Q, Chambon P, Gronemeyer H 1994 Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J 13:1414-1424
47. Zechel C, Shen X-Q, Chen Y, Chen Z-P, Chambon P, Gronemeyer H 1994 The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J 13:1425-1433
48. Tanaka M, Gupta R, Mayer BJ 1995 Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol Cell Biol 15:6829-6837
49. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1485
50. Casanova J, Helmer E, Selmi-Ruby S, Qi J-S, Au-Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HH 1994 Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14:5756-5765
51. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-455
52. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
53. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M 1994 Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367:476-480
54. Zhang X, Wills KN, Husmann M, Hermann T, Pfahl M 1991 Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 11:6016-6025
55. Yap N, Yu C-L, Cheng S-Y 1995 Modulation of the transcriptional activity of thyroid hormone receptors by the tumor supressor p53. Proc Natl Acad Sci USA 93:4273-4277
56. Desai-Yajnik V, Samuels HH 1993 The NF-kB and Sp1 motifs of the human immunodeficiency virus type I long terminal repeat function as novel thyroid hormone response elements. Mol Cell Biol 13:5057-5069
57. Desai-Yajnik V, Hadzic E, Modlinger P, Malhotra S, Gechlik G, Samuels HH 1995 Interactions of thyroid hormone receptor with the human immunodeficiency virus type I (HIV-I) long terminal repeat and the HIV-I Tat transactivator. J Virol 69:5103-5112
58. Ichikawa H, Shimizu K, Hayashi Y, Ohki M 1994 An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54:2865-2868
59. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Pater M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G 1992 Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162-165
60. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT 1994 A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146-151
61. Jeon I, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN 1995 A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncology 10:1229-1234
62. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G 1993 EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341-345
63. Gerald WL, Rosai J, Ladanyi M 1995 Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 92:1028-1032
64. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS 1996 Fusion of the EWS gene to GHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chrondrosarcoma. Oncogene 12:229-235
65. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT 1993 The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393-7398
66. Bailly R, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J 1994 DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in ewing sarcoma. Mol Cell Biol 14:3230-3241
67. Sanchez-Garcia I, Rabbitts TH 1994 Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci USA 91:7869-7873
68. Immanuel D, Zinszner H, Ron D 1995 Association of SARFH (Sarcoma-Associated RNA-Binding Fly Homolog) with regions of chromatin transcribed by RNA polymerase II. Mol Cell Biol 15:4562-4571
69. Stolow DT, Haynes SR 1995 Cabeza, a Drosophilia gene encoding a novel RNA-binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Proc Natl Acad Sci USA 23:835-843
70. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG 1993 hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289-321
71. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ESP 1994 The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncology 9:3087-3097
72. Calvio C, Neubauer G, Mann M, Lamond AI 1995 Identification of hnRNP P2 as TLS/FUS using electrospray mass spectroscopy. RNA. RNA 1:724-733
73. Del Rio S, Setzer DR 1993 The role of zinc fingers in transcriptional activation by transcription factor IIIA. Proc Natl Acad Sci USA 90:168-172
74. Milne CA, Segal J 1993 Mapping regions of yeast transcription factor IIIA required for DNA-binding, interaction with transcription factor IIIC, and transcriptional activity. J Biol Chem 268:11364-11371
75. Cook WJ, Mosley SP, Audino DC, Millaney DL, Rovelli A, Stewart G, Denis CL 1994 Mutations in the zinc-finger region of the yeast regulatory protein ADR1 affect both DNA-binding and transcriptional activation. J Biol Chem 269:9371-9379
76. Kurokawa R, Soderstrom M, Horlein AJ, Halachmi S, Brown M, Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
77. Sadovsky Y, Webb P, Lopez G, Baxter JD, Fitzpatrick PM, Gizang-Gingsberg E, Cavailles V, Parker MG, Kushner PJ 1995 Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol 15:1554-1563
78. Forman BM, Samuels HH 1991 pEXPRESS: a family of expression vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro. Gene 105:9-15
79. Sadowski I, Ma J, Triezenberg S, Ptashne M 1988 GAL4-VP-16 is an unusually potent transcriptional activator. Nature 335:563-564
80. Hard T, Kellenbach E, Boelens R, Maler BA, Dahlman K, Freedman LP, Carlstadt-Duke J, Yamamoto KR, Gustafsson J-A, Kaptein R 1990 Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249:157-160
81. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH 1992 Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol 6:429-442
82. Tempst P, Link AJ, Riviere LR, Fleming M, Elicone C 1990 Internal sequence analysis of proteins separated on polyacrylamide gels at the submicrogram level: improved methods, applications and gene cloning strategies. Electrophoresis 11:537-553
83. Fernandez J, Andrews L, Mische SM 1994 An improved procedure for enzymatic digestion of polyvinylidene difluoride-bound proteins for internal sequence analysis. Anal Biochem 218:112-117
84. Anthony PK, Stoltz RA, Pucci ML, Powers CA 1993 The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules and regulated release. Endocrinology 132:806-814